The DocTalk series, where we discuss current events in the industry and what they might mean for you. From news articles, research studies, pop culture, and everything in between, we’re going to break it all down and sift through the noise with the help of our expert, Dr. Janet Choi, Progyny’s Chief Medical Officer.
Today we’re spotlighting a study that’s been turning heads. This pilot study investigates how repurposing low doses of rapamycin, a drug originally used for patients undergoing an organ transplant, could potentially delay ovarian aging in women.
While this pilot study shows promise, it’s clear more research is needed. Listen to Dr. Choi unpack the science behind rapamycin and ovarian reserve, what this study found, and what this could mean for the future of fertility and women’s health.
Experts:
Dr. Janet Choi, Chief Medical Officer, Progyny
Lissa Kline, LCSW, Progyny
For more information, visit Progyny’s Education page. This show does not constitute medical advice.
Be sure to follow us on Instagram, @progynyinc, and subscribe to our YouTube channel for more resources.
Resources:
CNN: Commonly used drug may extend women’s fertility, claim researchers – here’s what you need to know about rapamycin: https://www.cnn.com/2024/07/31/health...
Vox: We have a drug that might delay menopause — and help us live longer: https://www.vox.com/future-perfect/36...
NPR: Rapamycin may slow aging. Here's one way the drug will be tested: https://www.npr.org/sections/shots-he...
Columbia University: Effect of Rapamycin in Ovarian Aging (Rapamycin): https://clinicaltrials.gov/study/NCT0...
Watch video DocTalk - Episode 6: Could this drug delay menopause? online without registration, duration hours minute second in high quality. This video was added by user Progyny 01 January 1970, don't forget to share it with your friends and acquaintances, it has been viewed on our site 17 once and liked it people.